Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: Is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience

Gynecologic Oncology

Volumn 116, Issue 1, 2010, Pages 38-43

  Jurado, Matías ^a   Alcázar, Juan Luis ^a   Martinez Monge, Rafael ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Pelvic exenteration; Recurrence; Resectability; Survival; Uterine cervical cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; PELVIS EXENTERATION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 70749132807     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.09.035     Document Type: Article

References (18)

1. Höckel M. Laterally extended endopelvic resection (LEER)-principles and practice. Gynecol. Oncol. 111 (2008) S13-S17
2. Höckel M., Sclenger K., Hamm H., Knapstein P.G., Hohenfellner R., and Rösler H.P. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 77 (1996) 1918-1933
3. Höckel M., and Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol. 7 (2006) 837-847
4. Barber H.R. Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg. Clin. North Am. 49 (1969) 431-447
5. Berek J.S., Howe C., Lagasse L.D., and Hacker N.F. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol. Oncol. 99 (2005) 153-159
6. Morley G.W., Hopkins M.P., Lindenauer S.M., and Roberts J.A. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet. Gynecol. 74 (1989) 934-943
7. Martínez-Monge R., Jurado M., Aristu J.J., Moreno M., Cambeiro M., Pérez-Ochoa A., et al. Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer. Gynecol. Oncol. 82 (2001) 538-543
8. Martínez-Monge R., Jurado M., Cambeiro M., Valero J., Villafranca E., and Alcázar J.L. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: initial results of a phase II trial. Brachytherapy 5 (2006) 203-210
9. Willett C.G., Czito B.G., and Tyler D.S. Intraoperative radiation therapy. J. Clin. Oncol. 25 (2007) 971-977
10. Morrow C.P., and Curtin J.P. Surgery for cervical neoplasia. In: Morrow C.P., and Curtin J.P. (Eds). Gynecologic cancer surgery (1996), Churchill Livingstone, New York 451-568
11. Höckel M. Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am. J. Obstet. Gynecol. 180 (1999) 306-312
12. Höckel M. Ultra-radical compartmentalized surgery in gynaecological oncology. Eur. J. Surg. Oncol. 32 (2006) 859-865
13. Jurado M., Bazán A., Alcázar J.L., and Garcia-Tutor E. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Ann. Surg. Oncol. 16 (2009) 121-127
14. Jurado M., Garcia-Tutor E., Botelle J., Gomez R., and Olartecoechea B. Vaginal reconstruction with a deep inferior epigastric perforator flap after pelvic exenteration. Gynecol. Oncol. 112 (2009) S2-S185
15. Höckel M., Baussmann E., Mitze M., and Knapstein P.G. Are pelvic side-wall recurrences of cervical cancer biologically different from central relapses?. Cancer 74 (1994) 648-655
16. Hori M., Kim T., Murakami T., Imaoka I., Onishi H., Tomoda K., et al. Uterine cervical carcinoma: preoperative staging with 3.0-T MR imaging-comparison with 1.5-T MR imaging. Radiology 251 (2009) 96-104
17. Larsen S.G., Wiig J.N., Emblemsvaag H.L., Grøholt K.K., Hole K.H., Bentsen A., et al. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging. Colorectal Dis. 11 (2009) 759-767
18. Vliegen R.F., Beets G.L., Lammering G., Dresen R.C., Rutten H.J., Kessels A.G., et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 246 (2008) 454-462